Mike Wenger
Mike Wenger is the founder and CEO of VersaTrial, a site enablement and engagement platform. For over 15 years, he has developed innovative solutions for the life sciences industry. Mike has lead teams at the Michael J. Fox Foundation and Epion Health and founded Clinical Trial Connect. After being acquired by TrialScope, he launched Citeline Connect, contributing to COVID-19 vaccine studies and connecting thousands of patients to research. With VersaTrial, Mike aims to improve relationships between clinical trial sites and pharma companies.
Author